Tag: Oncology

AmerisourceBergen and OneOncology in Long-Term Strategic Relationship

AmerisourceBergen, a global healthcare solutions leader, announced that it has entered a long-term strategic relationship with OneOncology, the national partnership of community oncologists driving th...

Immuno-Oncology Imaging Company in Collaboration with Roche

roche
ImaginAb Inc., a clinical stage immuno-oncology imaging company, announced today that it has entered into a non-exclusive license and collaboration agreement with Roche. Under the terms of the agreeme...

Sandoz Announced Launch of Generic Oncology Medicine Gefitinib in 13 EU Countries

Sandoz
Sandoz announced the launch of the generic oncology medicine gefitinib indicated for adult patients with locally advanced or metastatic non-small cell lung cancer with activating mutations of EGFR-TK,...

EMA to Review MAA for First China-Developed Trastuzumab Biosimilar

First trastuzumab developed in China following the National Medical Products Administration (NMPA) technical guideline for biosimilar with the New Drug Application (NDA) received the acceptance for re...

Pfizer Received FDA Approval for Avastin® Biosimilar

Pfizer Inc. today announced the United States (U.S.) Food and Drug Administration (FDA) has approved ZIRABEV™ (bevacizumab-bvzr), a biosimilar to Avastin® (bevacizumab), for the treatment of five type...

PhoenixMD and WuXi STA Produced Multikilogram Drug Supply for TNBC Treatment

PhoenixMD and WuXi STA have produced a multikilogram drug supply for PMD-026 under GMP manufacturing practices. Phoenix Molecular Designs (PhoenixMD), a privately-held biotechnology company designi...

Biocartis and Kite in Master Development and Commercialization Agreement

Biocartis Group NV, an innovative molecular diagnostics company (Euronext Brussels: BCART), today announced that it has entered into a Master Development and Commercialization Agreement with Kite, a G...

ProBioGen and Abcuro in GMP Manufacturing Agreement

ProBioGen AG, a premier service and technology provider for complex therapeutic antibodies and glycoproteins, announced the closing of a services and license agreement with Abcuro, Inc. Pursuing a new...

Pharmaceutical Companies Reported Strong Q1 Growth of Oncology Drugs Sales

Pharmaceutical companies have reported strong Q1 growth by their oncology drugs, based on earnings reports from Johnson & Johnson, Bristol-Myers Squibb, Bayer, Novartis and AbbVie. A report fro...

Collaboration on Developing First-in-Class Therapeutics for NSCLC

SK Biopharmaceuticals, a pharmaceutical company focused on disorders of central nervous system and cancer, and twoXAR, Inc., an artificial intelligence (AI)-driven biopharmaceutical company, announced...

Pharmasyntez—Official Distributor of Segidrin®

The Pharmasyntez Group of Companies became an official distributor of the drug product for palliative therapy Segidrin® (hydrazine sulphate) as a result of signing the Agreement with PJSC Pharmsynthez...

First Dose of Inovio’s dMAb™ Technology

Inovio Pharmaceuticals, Inc. in collaboration with The Wistar Institute and the University of Pennsylvania announced that the first subject was dosed as part of the first-ever human study of Inovio's ...

Anixa, Wistar Institute and Dmitry I. Gabrilovich Focus on MDSC

Anixa Biosciences, Inc., a biotechnology company focused on using the body's immune system to fight cancer, today announced it has extended its collaboration with The Wistar Institute and Dmitry I. Ga...

NICE Recommends Roche’s Breast Cancer Drug for Post-Surgery

NICE has published final draft guidance recommending pertuzumab (Perjeta, Roche) for treating early HER2-positive breast cancer in people whose disease has spread to their lymph nodes. This positiv...

3SBio and Verseau Partners in Immuno-Oncology Field

3SBio Inc. and Verseau Therapeutics, Inc. have announced a partnership agreement focused on the development and commercialization of novel monoclonal antibodies in the field of immuno-oncology for a b...

NeoTX in Clinical Collaboration with AstraZeneca

astrazeneca
NeoTX Therapeutics, Ltd announced that it has entered into a clinical collaboration with AstraZeneca Group Plc global biologics research and development arm, MedImmune, to support Phase 1b/2 studies i...